drugset / Trial / NCT02106962
Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients
Phase 4
Completed
17 enrolled
California Institute of Renal Research
Imprimis Pharmaceuticals, Inc. · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will investigate how the use of Tranexamic acid and Bacitracin applied to the bleeding site after the hemodialysis fistula needle is removed will affect Time to Clot and Infection Rate
Timeline
- Start
- 2014-04
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 5 % | Topical |
| Background | Bacitracin | Unknown | — | Topical |